| User's Publication |
|
21588
Miyako S, Koma YI, Nakanishi T, Tsukamoto S, Yamanaka K, Ishihara N, Azumi Y, Urakami S, Shimizu M, Kodama T, Nishio M, Shigeoka M, Kakeji Y, Yokozaki H.
Periostin in Cancer-Associated Fibroblasts Promotes Esophageal Squamous Cell Carcinoma Progression by Enhancing Cancer and Stromal Cell Migration.
Am J Pathol
2024
PubMed ID: 38320632
DOI: 10.1016/j.ajpath.2023.12.010
|
|
21907
Sasamori R, Sato Y, Nomura K, Wakita A, Nagaki Y, Kemuriyama K, Sasaki Y, Nozaki S, Takahashi T, Terata K, Imai K, Minamiya Y.
Lipopolysaccharide induces CCL2 through TLR4 signaling and promotes esophageal squamous cell carcinoma cell proliferation.
Am J Cancer Res
2024
14(7):3497-3512
PubMed ID: 39113860
DOI: 10.62347/EIKE6128
|
|
19768
Tsukamoto S, Koma YI, Kitamura Y, Tanigawa K, Azumi Y, Miyako S, Urakami S, Hosono M, Kodama T, Nishio M, Shigeoka M, Yokozaki H.
Matrix Metalloproteinase 9 Induced in Esophageal Squamous Cell Carcinoma Cells via Close Contact with Tumor-Associated Macrophages Contributes to Cancer Progression and Poor Prognosis
Cancers (Basel)
2023
15(11):2987
PubMed ID: 37296952
DOI: 10.3390/cancers15112987
|
|
19965
Azumi Y, Koma YI, Tsukamoto S, Kitamura Y, Ishihara N, Yamanaka K, Nakanishi T, Miyako S, Urakami S, Tanigawa K, Kodama T, Nishio M, Shigeoka M, Kakeji Y, Yokozaki H.
IFI16 Induced by Direct Interaction between Esophageal Squamous Cell Carcinomas and Macrophages Promotes Tumor Progression via Secretion of IL-1α
Cells
2023
12(22):2603
PubMed ID: 37998338
DOI: 10.3390/cells12222603
|
|
21054
Kitamura Y, Koma YI, Tanigawa K, Tsukamoto S, Azumi Y, Miyako S, Urakami S, Kodama T, Nishio M, Shigeoka M, Kakeji Y, Yokozaki H.
Roles of IL-7R Induced by Interactions between Cancer Cells and Macrophages in the Progression of Esophageal Squamous Cell Carcinoma.
Cancers (Basel)
2023
15(2)
PubMed ID: 36672342
DOI: 10.3390/cancers15020394
|
|
21077
Ishibashi Y, Mochizuki S, Horiuchi K, Tsujimoto H, Kouzu K, Kishi Y, Okada Y, Ueno H.
Periostin derived from cancer-associated fibroblasts promotes esophageal squamous cell carcinoma progression via ADAM17 activation.
Biochim Biophys Acta Mol Basis Dis
2023
1869(5):166669
PubMed ID: 36813090
DOI: 10.1016/j.bbadis.2023.166669
|
|
21175
Zhang X, Wang Y, Zhang X, Shen Y, Yang K, Ma Q, Qiao Y, Shi J, Wang Y, Xu L, Yang B, Ge G, Hu L, Kong X, Yang C, Chen Y, Ding J, Meng L.
Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitors.
Signal Transduct Target Ther
2023
8(1):153
PubMed ID: 37041169
DOI: 10.1038/s41392-023-01359-x
|
|
21406
Nguyen Vu TH, Kikuchi O, Ohashi S, Saito T, Ida T, Nakai Y, Cao Y, Yamamoto Y, Kondo Y, Mitani Y, Kataoka S, Kondo T, Katada C, Yamada A, Matsubara J, Muto M.
Combination therapy with WEE1 inhibition and trifluridine/tipiracil against esophageal squamous cell carcinoma.
Cancer Sci
2023
PubMed ID: 37724648
DOI: 10.1111/cas.15966
|
|
17626
Nomoto D, Baba Y, Liu Y, Tsutsuki H, Okadome K, Harada K, Ishimoto T, Iwatsuki M, Iwagami S, Miyamoto Y, Yoshida N, Watanabe M, Moroishi T, Komohara Y, Sawa T, Baba H.
Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression via the NOD1/RIPK2/NF-κB pathway
Cancer Lett
2022
530:59-67
PubMed ID: 35033591
DOI: 10.1016/j.canlet.2022.01.014
|
|
17703
Tanigawa K, Tsukamoto S, Koma YI, Kitamura Y, Urakami S, Shimizu M, Fujikawa M, Kodama T, Nishio M, Shigeoka M, Kakeji Y, Yokozaki H.
S100A8/A9 Induced by Interaction with Macrophages in Esophageal Squamous Cell Carcinoma Promotes the Migration and Invasion of Cancer Cells via Akt and p38 MAPK Pathways
Am J Pathol
2022
192(3):536-552
PubMed ID: 34954212
DOI: 10.1016/j.ajpath.2021.12.002
|
|
20614
Tsuchihashi K, Hirata Y, Yamasaki J, Suina K, Tanoue K, Yae T, Masuda K, Baba E, Akashi K, Kitagawa Y, Saya H, Nagano O.
Presence of spontaneous epithelial-mesenchymal plasticity in esophageal cancer.
Biochem Biophys Rep
2022
30:101246
PubMed ID: 35330672
DOI: 10.1016/j.bbrep.2022.101246
|
|
16095
Liu Y, Baba Y, Ishimoto T, Tsutsuki H, Zhang T, Nomoto D, Okadome K, Yamamura K, Harada K, Eto K, Hiyoshi Y, Iwatsuki M, Nagai Y, Iwagami S, Miyamoto Y, Yoshida N, Komohara Y, Ohmuraya M, Wang X, Ajani JA, Sawa T, Baba H.
Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma
Br J Cancer
2021
124(5):963-974
PubMed ID: 33299132
DOI: 10.1038/s41416-020-01198-5
|
|
16116
Kobayashi T, Makino T, Yamashita K, Saito T, Tanaka K, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Morii E, Eguchi H, Doki Y.
APR-246 induces apoptosis and enhances chemo-sensitivity via activation of ROS and TAp73-Noxa signal in oesophageal squamous cell cancer with TP53 missense mutation
Br J Cancer
2021
125(11):1523-1532
PubMed ID: 34599296
DOI: 10.1038/s41416-021-01561-0
|
|
12098
Yamazaki S, Su Y, Maruyama A, Makinoshima H, Suzuki J, Tsuboi M, Goto K, Ochiai A, Ishii G.
Uptake of collagen type I via macropinocytosis cause mTOR activation and anti-cancer drug resistance.
Biochem. Biophys. Res. Commun.
2020
PubMed ID: 32201076
DOI: 10.1016/j.bbrc.2020.03.067
|
|
13600
Sano H, Futamura M, Gaowa S, Kamino H, Nakamura Y, Yamaguchi K, Tanaka Y, Yasufuku I, Nakakami A, Arakawa H, Yoshida K.
p53/Mieap-regulated mitochondrial quality control plays an important role as a tumor suppressor in gastric and esophageal cancers
Biochem Biophys Res Commun
2020
529(3):582-589.
PubMed ID: 32736677
DOI: 10.1016/j.bbrc.2020.05.168
|
|
13609
Okamoto M, Koma YI, Kodama T, Nishio M, Shigeoka M, Yokozaki H.
Growth Differentiation Factor 15 Promotes Progression of Esophageal Squamous Cell Carcinoma via TGF-β Type II Receptor Activation
Pathobiology
2020
87(2):100-113
PubMed ID: 31896114
DOI: 10.1159/000504394
|
|
14800
Ohashi S, Kikuchi O, Nakai Y, Ida T, Saito T, Kondo Y, Yamamoto Y, Mitani Y, Nguyen Vu TH, Fukuyama K, Tsukihara H, Suzuki N, Muto M.
Synthetic Lethality with Trifluridine/Tipiracil and Checkpoint Kinase 1 Inhibitor for Esophageal Squamous Cell Carcinoma
Mol Cancer Ther
2020
19(6):1363-1372
PubMed ID: 32371587
DOI: 10.1158/1535-7163.MCT-19-0918
|
|
11526
Liu J, Min L, Zhu S, Guo Q, Li H, Zhang Z, Zhao Y, Xu C, Zhang S.
Cyclin-Dependent Kinase Inhibitor 3 Promoted Cell Proliferation by Driving Cell Cycle from G1 to S Phase in Esophageal Squamous Cell Carcinoma.
J Cancer
2019
PubMed ID: 31205550
DOI: 10.7150/jca.27053
|
|
11791
Shin WS, Lee HW, Lee ST.
Catalytically inactive receptor tyrosine kinase PTK7 activates FGFR1 independent of FGF.
FASEB J.
2019
PubMed ID: 31490704
DOI: 10.1096/fj.201900932R
|
|
11699
Kiyozumi Y, Baba Y, Okadome K, Yagi T, Ogata Y, Eto K, Hiyoshi Y, Ishimoto T, Iwatsuki M, Iwagami S, Miyamoto Y, Yoshida N, Watanabe M, Baba H.
Indoleamine 2, 3-dioxygenase 1 promoter hypomethylation is associated with poor prognosis in patients with esophageal cancer.
Cancer Sci
2019
110(6):1863-1871
PubMed ID: 31012515
DOI: 10.1111/cas.14028
|
|
12594
Kalikawe R, Baba Y, Nomoto D, Okadome K, Miyake K, Eto K, Hiyoshi Y, Nagai Y, Iwatsuki M, Ishimoto T, Iwagami S, Miyamoto Y, Yoshida N, Watanabe M, Baba H.
Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal cancer
Cancer Sci
2019
110(12):3727-3737
PubMed ID: 31599475
DOI: 10.1111/cas.14214
|
|
12595
Sawayama H, Ogata Y, Ishimoto T, Mima K, Hiyoshi Y, Iwatsuki M, Baba Y, Miyamoto Y, Yoshida N, Baba H.
Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer
Cancer Sci
2019
110(5):1705-1714
PubMed ID: 30861255
DOI: 10.1111/cas.13995
|
|
10798
Shinno N, Kimura H, Sada R, Takiguchi S, Mori M, Fumoto K, Doki Y, Kikuchi A.
Activation of the Dickkopf1-CKAP4 pathway is associated with poor prognosis of esophageal cancer and anti-CKAP4 antibody may be a new therapeutic drug.
Oncogene
2018
37(26):3471-3484
PubMed ID: 29563607
DOI: 10.1038/s41388-018-0179-2
|
|
11092
Shin WS, Gim J, Won S, Lee ST.
Biphasic regulation of tumorigenesis by PTK7 expression level in esophageal squamous cell carcinoma.
Sci Rep
2018
8(1):8519
PubMed ID: 29867084
DOI: 10.1038/s41598-018-26957-6
|
|
11369
Li SH, Lu HI, Huang WT, Chen YH, Lo CM, Lan YC, Lin WC, Tsai HT, Chen CH.
An actin-binding protein ESPN is an independent prognosticator and regulates cell growth for esophageal squamous cell carcinoma.
Cancer Cell Int.
2018
PubMed ID: 30618491
DOI: 10.1186/s12935-018-0713-x
|
|
4355
Furukawa H, Makino T, Yamasaki M, Tanaka K, Miyazaki Y, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y.
PRIMA-1 induces p53-mediated apoptosis by upregulating Noxa in esophageal squamous cell carcinoma with TP53 missense mutation.
Cancer Sci.
2018
109(2):412-421
PubMed ID: 29168598
DOI: 10.1111/cas.13454
|
|
4357
Kim MJ, Choi SK, Hong SH, Eun JW, Nam SW, Han JW, You JS.
Oncogenic IL7R is downregulated by histone deacetylase inhibitor in esophageal squamous cell carcinoma via modulation of acetylated FOXO1.
Int. J. Oncol.
2018
53(1):395-403
PubMed ID: 29749437
DOI: 10.3892/ijo.2018.4392
|
|
4504
Piao L, Yang Z, Jin J, Ni W, Qi W, Xuan Y.
B7H4 is associated with stemness and cancer progression in esophageal squamous cell carcinoma.
Hum. Pathol.
2018
80:152-162
PubMed ID: 29885401
DOI: 10.1016/j.humpath.2018.05.021
|
|
4505
Yang Z, Ni W, Cui C, Qi W, Piao L, Xuan Y.
Identification of LETM1 as a marker of cancer stem-like cells and predictor of poor prognosis in esophageal squamous cell carcinoma.
Hum. Pathol.
2018
81:148-156
PubMed ID: 30031102
DOI: 10.1016/j.humpath.2018.07.001
|
|
9448
Chihiro Kajiwara, Katsumi Fumoto, Hirokazu Kimura, Satoshi Nojima, Keita Asano, Kazuki Odagiri, Makoto Yamasaki, Hayato Hikita, Tetsuo Takehara, Yuichiro Doki, Eiichi Morii, Akira Kikuchii
p63-Dependent Dickkopf3 Expression Promotes Esophageal Cancer Cell Proliferation via CKAP4
Cancer Res
2018
78(21):6107-6120
PubMed ID: 30181180
DOI: 10.1158/0008-5472.CAN-18-1749
|
|
13126
Gaowa S, Futamura M, Tsuneki M, Kamino H, Tajima JY, Mori R, Arakawa H, Yoshida K.
Possible role of p53/Mieap-regulated mitochondrial quality control as a tumor suppressor in human breast cancer.
Cancer Sci
2018
PubMed ID: 30290054
DOI: 10.1111/cas.13824
|
|
10004
Iwaya T, Sawada G, Amano S, Kume K, Ito C, Endo F, Konosu M, Shioi Y, Akiyama Y, Takahara T, Otsuka K, Nitta H, Koeda K, Mizuno M, Nishizuka S, Sasaki A, Mimori K.
Downregulation of ST6GALNAC1 is associated with esophageal squamous cell carcinoma development.
Int. J. Oncol.
2017
50:441-447
PubMed ID: 28035351
DOI: 10.3892/ijo.2016.3817
|
|
10141
Sugase T, Takahashi T, Serada S, Nakatsuka R, Fujimoto M, Ohkawara T, Hara H, Nishigaki T, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Kishimoto T, Mori M, Doki Y, Naka T.
Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice.
Int. J. Cancer
2017
140:2608-2621
PubMed ID: 28233302
DOI: 10.1002/ijc.30666
|
|
10353
Kawaguchi T, Komatsu S, Ichikawa D, Hirajima S, Nishimura Y, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Tsuda H, Otsuji E.
Overexpression of TRIM44 is related to invasive potential and malignant outcomes in esophageal squamous cell carcinoma.
Tumour Biol.
2017
39:1010428317700409
PubMed ID: 28618928
DOI: 10.1177/1010428317700409
|
|
10365
Yamamoto M, Yamasaki M, Tsukao Y, Tanaka K, Miyazaki Y, Makino T, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y.
Poly (ADP-ribose) polymerase-1 inhibition decreases proliferation through G2/M arrest in esophageal squamous cell carcinoma.
Oncol Lett
2017
14:1581-1587
PubMed ID: 28789382
DOI: 10.3892/ol.2017.6334
|
|
9599
Kikuchi O, Ohashi S, Horibe T, Kohno M, Nakai Y, Miyamoto S, Chiba T, Muto M, Kawakami K.
Novel EGFR-targeted strategy with hybrid peptide against oesophageal squamous cell carcinoma.
Sci Rep
2016
6:22452
PubMed ID: 26956916
DOI: 10.1038/srep22452
|
|
9724
Hara H, Takahashi T, Serada S, Fujimoto M, Ohkawara T, Nakatsuka R, Harada E, Nishigaki T, Takahashi Y, Nojima S, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Miyata H, Nakajima K, Takiguchi S, Morii E, Mori M, Doki Y, Naka T.
Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma.
Br. J. Cancer
2016
115:66-75
PubMed ID: 27310703
DOI: 10.1038/bjc.2016.183
|
|
10892
RXDX-107, A Dodecanol Alkyl Ester of Bendamustine, Demonstrates Greater Stability and Broad Antitumor Activity in Multiple Pre-Clinical Models of Solid Tumor
Chemo Open Access
2016
5:3
DOI: 10.4172/2167-7700.1000213
|
|
9433
Yunyan Wu, Qiang Liu, Xu Yan, Yukio Kato, Makiko Tanaka, Sadaki Inokuchi, Tadashi Yoshizawa, Satoko Morohashi, Hiroshi Kijima
Podoplanin-mediated TGF-β-induced Epithelial-Mesenchymal Transition and Its Correlation With bHLH Transcription Factor DEC in TE-11 Cells
Int J Oncol
2016
48(6):2310-20
PubMed ID: 27035755
DOI: 10.3892/ijo.2016.3445
|
|
12618
Kosumi K, Baba Y, Sakamoto A, Ishimoto T, Harada K, Nakamura K, Kurashige J, Hiyoshi Y, Iwatsuki M, Iwagami S, Sakamoto Y, Miyamoto Y, Yoshida N, Oki E, Watanabe M, Hino S, Nakao M, Baba H.
Lysine-specific demethylase-1 contributes to malignant behavior by regulation of invasive activity and metabolic shift in esophageal cancer
Int J Cancer
2016
138(2):428-39
PubMed ID: 26240060
DOI: 10.1002/ijc.29714
|
|
12664
Shin WS, Hong Y, Lee HW, Lee ST.
Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-κB in esophageal squamous cell carcinoma cells
Oncotarget
2016
7(45):73242-73256
PubMed ID: 27689325
DOI: 10.18632/oncotarget.12303
|
|
12903
Nishio M, Urakawa N, Shigeoka M, Takase N, Ichihara Y, Arai N, Koma Y, Yokozaki H.
Software-assisted morphometric and phenotype analyses of human peripheral blood monocyte-derived macrophages induced by a microenvironment model of human esophageal squamous cell carcinoma
Pathol Int
2016
66(2):83-93
PubMed ID: 26778807
DOI: 10.1111/pin.12381
|
|
12969
Hamada J, Shoda K, Masuda K, Fujita Y, Naruto T, Kohmoto T, Miyakami Y, Watanabe M, Kudo Y, Fujiwara H, Ichikawa D, Otsuji E, Imoto I.
Tumor-promoting function and prognostic significance of the RNA-binding protein T-cell intracellular antigen-1 in esophageal squamous cell carcinoma
Oncotarget
2016
7(13):17111-28
PubMed ID: 26958940
DOI: 10.18632/oncotarget.7937
|
|
13992
Nakamura K, Baba Y, Kosumi K, Harada K, Shigaki H, Miyake K, Kiyozumi Y, Ohuchi M, Kurashige J, Ishimoto T, Iwatsuki M, Sakamoto Y, Yoshida N, Watanabe M, Nakao M, Baba H.
UHRF1 regulates global DNA hypomethylation and is associated with poor prognosis in esophageal squamous cell carcinoma
Oncotarget
2016
7(36):57821-5783
PubMed ID: 27507047
DOI: 10.18632/oncotarget.11067
|
|
14119
Park M, Yoon HJ, Kang MC, Kwon J, Lee HW.
PTK7 regulates radioresistance through nuclear factor-kappa B in esophageal squamous cell carcinoma
Tumour Biol
2016
37(10):14217-14224
PubMed ID: 27557627
DOI: 10.1007/s13277-016-5288-3
|
|
14129
Ogiwara H, Sasaki M, Mitachi T, Oike T, Higuchi S, Tominaga Y, Kohno T.
Targeting p300 Addiction in CBP-Deficient Cancers Causes Synthetic Lethality by Apoptotic Cell Death due to Abrogation of MYC Expression
Cancer Discov
2016
6(4):430-45
PubMed ID: 26603525
DOI: 10.1158/2159-8290.CD-15-0754
|
|
7225
Mikami T, Yoshida K, Sawada H, Esaki M, Yasumura K, Ono M.
Inhibition of Rho-associated kinases disturbs the collective cell migration of stratified TE-10 cells.
Biol. Res.
2015
48:48
PubMed ID: 26330114
DOI: 10.1186/s40659-015-0039-2
|
|
7327
Tanaka K, Miyata H, Sugimura K, Fukuda S, Kanemura T, Yamashita K, Miyazaki Y, Takahashi T, Kurokawa Y, Yamasaki M, Wada H, Nakajima K, Takiguchi S, Mori M, Doki Y.
miR-27 is associated with chemoresistance in esophageal cancer through transformation of normal fibroblasts to cancer-associated fibroblasts.
Carcinogenesis
2015
36:894-903
PubMed ID: 26026166
DOI: 10.1093/carcin/bgv067
|
|
7350
Nabeki B, Ishigami S, Uchikado Y, Sasaki K, Kita Y, Okumura H, Arigami T, Kijima Y, Kurahara H, Maemura K, Natsugoe S.
Interleukin-32 expression and Treg infiltration in esophageal squamous cell carcinoma.
Anticancer Res.
2015
35:2941-7
PubMed ID: 25964580
|
|
7382
Saito S, Morishima K, Ui T, Hoshino H, Matsubara D, Ishikawa S, Aburatani H, Fukayama M, Hosoya Y, Sata N, Lefor AK, Yasuda Y, Niki T.
The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma.
BMC Cancer
2015
15:82
PubMed ID: 25884729
DOI: 10.1186/s12885-015-1065-8
|
|
15184
Harada K, Baba Y, Ishimoto T, Kosumi K, Tokunaga R, Izumi D, Ohuchi M, Nakamura K, Kiyozumi Y, Kurashige J, Iwagami S, Miyamoto Y, Sakamoto Y, Yoshida N, Oki E, Watanabe M, Baba H.
Suppressor microRNA-145 Is Epigenetically Regulated by Promoter Hypermethylation in Esophageal Squamous Cell Carcinom
Anticancer Res
2015
35(9):4617-24
PubMed ID: 26254350
|
|
15229
Shigeoka M, Urakawa N, Nishio M, Takase N, Utsunomiya S, Akiyama H, Kakeji Y, Komori T, Koma Y, Yokozaki H.
Cyr61 promotes CD204 expression and the migration of macrophages via MEK/ERK pathway in esophageal squamous cell carcinoma
Cancer Med
2015
4(3):437-46
PubMed ID: 25620088
DOI: 10.1002/cam4.401
|
|
19049
Kwon J, Yoon HJ, Kim JH, Lee TS, Song IH, Lee HW, Kang MC, Park JH.
Cetuximab inhibits cisplatin-induced activation of EGFR signaling in esophageal squamous cell carcinoma
Oncol Rep
2014
32(3):1188-92
PubMed ID: 24993015
DOI: 10.3892/or.2014.3302
|
|
13765
Sawayama H, Ishimoto T, Watanabe M, Yoshida N, Sugihara H, Kurashige J, Hirashima K, Iwatsuki M, Baba Y, Oki E, Morita M, Shiose Y, Baba H.
Small molecule agonists of PPAR-γ exert therapeutic effects in esophageal cancer
Cancer Res
2014
74(2):575-85
PubMed ID: 24272485
DOI: 10.1158/0008-5472.CAN-13-1836
|
|
15822
Ohashi S, Kikuchi O, Tsurumaki M, Nakai Y, Kasai H, Horimatsu T, Miyamoto S, Shimizu A, Chiba T, Muto M.
Preclinical validation of talaporfin sodium-mediated photodynamic therapy for esophageal squamous cell carcinoma
PLoS One
2014
9(8):e103126
PubMed ID: 25090101
DOI: 10.1371/journal.pone.0103126
|
|
17149
Yeo SY, Ha SY, Yu EJ, Lee KW, Kim JH, Kim SH.
ZNF282 (Zinc finger protein 282), a novel E2F1 co-activator, pr
Oncotarget
2014
5(23):12260-72
PubMed ID: 25373738
DOI: 10.18632/oncotarget.2630
|
|
18742
Sugimura K, Miyata H, Tanaka K, Hamano R, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Mori M, Doki Y.
Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma
Clin Cancer Res
2012
18(18):5144-53
PubMed ID: 22847808
DOI: 10.1158/1078-0432.CCR-12-0701
|
|
18266
Yamada A, Fujii S, Daiko H, Nishimura M, Chiba T, Ochiai A.
Aberrant expression of EZH2 is associated with a poor outcome and P53 alteration in squamous cell carcinoma of the esophagus
Int J Oncol
2011
38(2):345-53
PubMed ID: 21165554
DOI: 10.3892/ijo.2010.868
|
|
19034
Hamano R, Miyata H, Yamasaki M, Kurokawa Y, Hara J, Moon JH, Nakajima K, Takiguchi S, Fujiwara Y, Mori M, Doki Y.
Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway
Clin Cancer Res
2011
17(9):3029-38
PubMed ID: 21248297
DOI: 10.1158/1078-0432.CCR-10-2532
|
|
12745
Matsushima K, Isomoto H, Yamaguchi N, Inoue N, Machida H, Nakayama T, Hayashi T, Kunizaki M, Hidaka S, Nagayasu T, Nakashima M, Ujifuku K, Mitsutake N, Ohtsuru A, Yamashita S, Korpal M, Kang Y, Gregory PA, Goodall GJ, Kohno S, Nakao K.
MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells
J Transl Med
2011
9:30
PubMed ID: 21426561
DOI: 10.1186/1479-5876-9-30
|
|
12755
Inoue N, Isomoto H, Matsushima K, Hayashi T, Kunizaki M, Hidaka S, Machida H, Mitsutake N, Nanashima A, Takeshima F, Nakayama T, Ohtsuru A, Nakashima M, Nagayasu T, Yamashita S, Nakao K, Kohno S.
Down-regulation of microRNA 10a expression in esophageal squamous cell carcinoma cells
Oncol Lett
2010
1(3):527-531
PubMed ID: 22966337
DOI: 10.3892/ol_00000093
|
|
6410
Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.
Is parainfluenza virus a threatening virus for human cancer cell lines?
Hum Cell
2009
22(3):81-4
PubMed ID: 19624309
DOI: 10.1111/j.1749-0774.2009.00071.x
|
Back
Top
CELL BANK Website